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ABSTRACT 
 
Introduction: Neglected tropical diseases (NTDs) are important public health problems in 
Ethiopia. In 2013, the Federal Ministry of Health (FMOH) has launched a national NTD master 
plan to eliminate major NTDs of public health importance by 2020. Benchmarking the current 
status of NTDs in the country is important to monitor and evaluate the progress in the 
implementation of interventions and their impacts. Therefore, this study aims to assess the trends 
of mortality and Disability-adjusted Life-Years (DALY) for the priority NTDs over the last 25 
years.  
Methods: We used the Global Burden of Disease (GBD) 2015 estimates for this study. The GBD 
2015 data source for cause of death and DALY estimation included verbal autopsy (VA), 
Demographic and Health Surveys (DHS), malaria indicator surveys (MICS) and other disease 
specific surveys, Ministry of Health reports submitted to United Nations (UN) agencies and 
published scientific articles. Cause of Death Ensemble modeling (CODEm) and/or natural history 
models were used to estimate malaria and NTDs mortality rates. DALY were estimated as the sum 
of Years of Life Lost (YLL) due to premature mortality and Years Lived with Disability (YLD).  
Results: All NTDs caused an estimated of 6,293 deaths (95% uncertainty interval (UI): 3699 – 
10,080) in 1990 and 3,593 deaths (95% UI: 2051 – 6178) in 2015, a 70% reduction over the 25 
years. Age-standardised mortality rates due to schistosomiasis, STH and leshmaniasis have 
declined by 91.3%, 73.5% and 21.6% respectively between 1990 to 2015. The number of DALYs 
due to all NTDs has declined from 814.4 thousand (95% UI: 548 thousand–1.2 million) in 1990 
to 579.5 thousand (95%UI: 309.4 thousand – 1.3 million) in 2015. Age-standardised DALY rates 
due to all NTDs declined by 30.4%, from 17.6 per 1000(95%UI: 12.5-26.5) in 1990 to 12.2 per 
1000(95%UI: 6.5 – 27.4) in 2015.  Age-standardised DALY rate for trachoma declined from 92.7 
per 100,000(95% UI: 63.2 – 128.4) in 1990 to 41.2 per 100,000(95%UI: 27.4 – 59.2) in 2015, a 
55.6% reduction between 1990 and 2015. Age-standardised DALY rates for onchocerciasis, 
schistosomiasis and lymphiatic filariasis decreased by 66.2%, 29.4% and 12.5% respectively 
between 1990 and 2015. DALY rate for ascariasis fell by 56.8% over the past 25 years.  
Conclusions: Ethiopia has made a remarkable progress in reducing the DALY rates for most of 
the NTDs over the last 25 years. The rapid scale of interventions and broader system strengthening 
may have a lasting impact on achieving the 2020 goal of elimination of most of NTDs. Ethiopia 
should strengthen the coverage of integrated interventions of NTD through proper coordination 
with other health programs and sectors and community participation to eliminate NTDs by 2020. 
  
INTRODUCTION 
 
Ethiopia has demonstrated significant progress in the health sector and has been described as one 
of the success stories to deliver health services at low cost[1]. The country achieved most of the 
health related Millennium Development Goals (MDSs) by 2013[2].  Despite this significant 
progress, communicable diseases including neglected tropical diseases (NTDs) remain the major 
public health problems of the country during the Sustainable Development Goals (SDG) era. To 
address these important public health problems, Ethiopia launched its first NTD master plan in 
2013[3,4].  Eight NTDs have been prioritized in the master plan: lymphiatic filariasis (LF), 
onchocerciasis, schistosomiasis, soil transmitted helminths (STH), leishmaniasis, trachoma, 
podoconiasis and dracunculiasis [3-5].  
 
Neglected tropical diseases (NTDs) are a cluster of tropical diseases that affect more than one 
billion people worldwide, they occur mainly among poor populations who have low access to the 
health care system. NTDs can cause disability, disfigurement, undernutrition and cognitive 
impairments, yet most of them can easily be controlled and prevented[6,7]. The global effort to 
control NTDs was shaped by the launching of the WHO NTD Roadmap in 2012[8] and through 
the London declaration, where partners, donors and pharmaceutical companies pledged to 
eliminate 10 NTDs by 2020[9].   
 
Ethiopia has completed the mapping of most of the NTDs. The results suggest that in 2013 there 
were an estimated 80 million Ethiopians living in areas that are endemic to one or more of NTDs 
[10].  Considering the high burden and public health impacts of NTDs, the Federal Ministry of 
Health (FMOH)and development partners have collaborated to implement high impact 
interventions such as mass drug administration (MDA), integrated vector control measures, 
intensified case management and environmental sanitation and safe water supply over the last 
decade[10,11].  
 
The national NTD master plan envisaged to control and eliminate the eight priority NTDs. The 
master plan focuses on four pillar strategies to achieve its goal: government ownership and 
partnership; enhance planning for financial sustainability; scale up of high impact interventions 
through community participation; and enhance monitoring and evaluation, surveillance and 
research [5]. As stipulated in the master plan monitoring and evaluation of the program impact are 
progress are important. The prerequisite for the implementation of effective program monitoring 
and evaluation is benchmarking. Nonetheless, despite their importance the mortality and Disability 
Adjusted life-years (DALY) due to NTDs have not been comprehensively evaluated in Ethiopia. 
In this paper, we used the GBD 2015 estimates [11,12] to assess mortality and DALY trends for 
common NTDs such as LF, onchocerciasis, schistosomiasis, soil transmitted helminthiasis (STH), 
leishmaniasis, and trachoma over the last 25 years.  These estimates provide important insights 
into the performance of Ethiopia during the MGD era, and serve as benchmark to track future 
progress during the SDG period.  
 
  
METHODS 
 
 
Settings: 
Ethiopia has an estimated population of 94 million, the second largest in Africa, and 86% the 
population live in rural areas [13].The country has nine regional states and two city administrations 
which are further divided into Woredas and Kebeles (lowest administrative units). Ethiopia has a 
decentralized health care delivery system and the national health policy focuses on both health 
promotion and disease prevention, and curative services. The country has launched an innovative 
Health Extension Programme (HEP) in 2003 to deliver cost-effective basic health services to all 
Ethiopians at the grass root level, mainly women and children through the health extension 
workers[14,15]. 
 
Data sources: 
GBD 2015 data sources for Ethiopia have been detailed elsewhere[2]. In brief, the 2015 GBD data 
sources for estimation of causes of death and DALYs included verbal autopsy (VA), Demographic 
and Health Surveys (DHS), malaria indicator surveys (MICS)and other disease specific surveys, 
FMOH reports submitted to United Nations(UN) agencies and published scientific articles [2,16-
18].  
 
Causes of death modeling: 
The data analysis for this paper is part of the GBD global data analysis framework that included 
seven supper regions, 21 regions and 195 countries [11,12].  The detailed data analysis steps and 
techniques to estimate cause-specific mortality rates [2,11,19] and DALYs [17,18] are published 
elsewhere. Briefly, the GBD cause list relies on assigning a single cause for each death in 
accordance with the principle of International Classification of Diseases (ICD). The cause of death 
(i.e. underlying cause of death) may initiate a series of events leading to death [11,17,19]. In the 
first step, the causes of death (CoD) database was developed from the main data sources as 
described earlier. During the database development, multiple data formats were standardized to a 
single GBD standard and each ICD or verbal autopsy variant was mapped to the GBD cause list. 
Deaths assigned to causes that cannot be underlying causes of death (i.e., garbage coded) were re-
assigned to their likely underlying cause of death [11,20]. Cause of Death Ensemble modeling 
(CODEm) and/or natural history models were used to estimate NTDs and malaria related mortality 
rates.  Detail descriptions of CODEm are published elsewhere [16,20-22].  In short, CODEm tests 
a wide range of sub-models that vary based on model type (mixed effects linear models versus 
spatial-temporal Gaussian process regression (ST-GPR) models), outcome (mortality rate versus 
cause fraction) and covariate selection.  Each sub-model is tested for out-of-sample predictive 
performance using cross-validation, and the final estimates are based on an ensemble of the best 
performing sub-models [16]. A natural history model was applied to estimate leishmaniasis 
mortality rate. This is because leishmaniasis mortality is not captured in VA due to either 
geographic location of death or potential systematic bias in VA methodology[11]. Similarly, for 
malaria in sub-Saharan Africa including Ethiopia, a natural history model was used based on the 
incidence estimated by the Malaria Atlas Project and age–sex-specific case-fatality rates estimated 
from available data[11]. 
 
 
Estimation of DALY: 
Detailed DALY estimation methods were described in previous GBD publications [12,23]. In 
summary, DALY combines years of life lost (YLL) due to premature mortality and years lived 
with disability (YLD), a measure of non-fatal health loss, in a single metric. One DALY can be 
thought of as one lost year of healthy life. YLL were estimated using standard GBD methods 
whereby each death is multiplied by the normative standard life expectancy at each age. The 
normative standard life expectancy at birth is 86·59 years, based on the lowest observed death 
rates for each 5-year age group in populations larger than 5 million.  YLD were estimated using 
sequelae prevalence and disability weights derived from population-based surveys of the general 
public to assign disability weights to each sequela and combination of sequelae [12,23].  
 
Ethical considerations: 
Permission to conduct this study was sought from the Institute of Health Metrics and Evaluation 
in Washington University in Seattle. The study follows the World Health Organization(WHO) 
Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER)[11] 
 
RESULTS 
 
All NTDs caused an estimated of 6,293 deaths (95% uncertainty interval, UI: 3699 – 10,080) in 
1990 and 3,593 deaths (95% UI: 2051 – 6178) in 2015, a 70% reduction over the 25 years. Age-
standardised mortality rates due to schistosomiasis was 6.1/100,000 (95% UI: 3.5-9.4) in 1990 and 
0.53/100,000 (95% UI: 0.23–1.0) in 2015, a 91.3% reduction over the 25 years. Age-standardised 
mortality rates due to all NTDs declined by 70% between 1990 and 2015(Table 1). Age-
standardised mortality rates for schistosomiasis, STH and rabies have declined by 91.3%, 70.1% 
and 73.5% respectively, between 1990 and 2015. The annualized mortality rate of change (ARC) 
for all NTD was 5% (95% UI: 3.4-7.6%). The least progress in terms of median % of mortality 
change (21.6%) was observed for leishmaniasis during 1990-2015 (Table 1 and figure1).  
 
Will Insert Table 1 and Figure 1 here 
 
STH mortality rates peaked in the age group of 1-4 years for males (0.76 per 100,000; 95%UI: 
0.32-1.36) and females (0.71 per 100,000; 95% UI: 0.29-1.27)(Figure 2a). Schistosomiasis 
mortality rates rose substantially as age increased (Figure 2b). Leishmaniasis mortality rates were 
higher among males were more than 5 times higher than mortality rate among females for 
individuals older than 10 years (Figure 2c).  
 
Will Insert Figures 2a-2c here 
 
The number of DALY due to all NTDs has declined from 814.4 thousand (95% UI: 548 thousand 
– 1.2 million) in 1990 to 579.5 thousand (95%UI: 309.4 thousand – 1.3 million) in 2015. Age-
standardised DALY rates due to all NTDs declined by 30.4%, from 17.6 per 1000 (95%UI: 12.5-
26.5) in 1990 to 12.2 per 1000 (95%UI: 6.5 – 27.4) in 2015.  Age-standardised DALY rate for 
trachoma declined from 92.7 per 100,000 (95% UI: 63.2 – 128.4) in 1990 to 41.2 per 100,000 
(95%UI: 27.4 – 59.2) in 2015, a 55.6% reduction between 1990 and 2015. Age-standardised 
DALY rates for onchocerciasis, schistosomiasis and LF decreased by 66.2%, 29.4% and 12.5% 
respectively between 1990 and 2015. DALY rate for ascariasis fell by 56.8% over the past 25 years 
(Table 2).  
 
Will Insert Table 2 here 
 
 
The age-standardised DALY rates for rabies, onchocerciasis and trachoma declined by 19.5%, 
18.5% 14.0% respectively annually during 1990 and 2015. The smallest ARC for DALY rates was 
for LF (2.2%) during the same period (Figure 3).  
 
Will Insert Figure 3 here 
 
DALY rates for LF progressively increased with age and were more than five times higher among 
males than among females in all age groups (Figure 4a). Trachoma DALY rates increased 
significantly with age, with trachoma DALY rates being more than 200 per 100,000 among 
females 65 years and older, compared to 0.9 per 100,000 among females ages 15-19 years (Figure 
4b).   
 
DISCUSSION 
 
In recent years unprecedented support for the NTDs has been given globally. The launching of the 
World Health Organization NTD roadmap and the London declaration contributed to this global 
momentum[8,9]. In line with this global increased commitment Ethiopia launched the first ever 
NTD master plan in 2013 and renewed the second master plan in 2016[3,4]. To monitor and 
evaluate the impact of interventions and to track the progress in the NTD control and elimination 
it is critical to have robust benchmark. This study advances that goal and provides important 
account to the progress and current status of NTDs burden in Ethiopia. 
 
This study presents a comprehensive evaluation of mortality and DALYs for common NTDs in 
Ethiopia between 1990 and 2015. Ethiopia has made remarkable progress in reducing the burden 
of NTDs during the MDG era. Age-standardized mortality rates for schistosomiasis have declined 
by more than 91.3% over the last 25 years. Age-standardised DALY rates for trachoma and 
onchocerciasis have decreased by more than 50% during the same period. However, less progress 
was observed for LF, leishmaniasis, trichuriasis, for which DALY rates declined by 12%, 17.5%, 
and 2.3%, respectively. On the other hand, DALY rates have increased by nearly 4% for 
hookworm during the MDG era.  
 
NTDs are diseases of poverty and they affect the most disadvantaged and vulnerable population, 
particularly in Sub-Saharan Africa and Ethiopia. Poor housing conditions, illiteracy, lack of safe 
water supply and poor sanitations are among the strongest risk factors for NTDs, and these risks 
are common in sub-Saharan Africa [24]. Several NTDs such as LF, onchocerciasis and Trachoma 
are non-fatal; and their public health impact is, therefore, best understood in terms of DALYs[24]. 
Ethiopia has made significant progress in reducing health loss from most NTDs. First, the rapid 
economic growth in the country over the last two decades could have positive impact in reducing 
the burden of poverty related NTDs[2]. Second, the FMOH in collaboration with implementing 
partners and donors have launched and improved the coverage of integrated and effective 
interventions such as mass drug administration (MDA), integrated vector control activities, SAFE 
for trachoma (surgery, antibiotics, face washing and environmental sanitation) and intensified case 
management.  These interventions likely underlie the observed reductions in the burden of 
NTDs[5,10,25].  As of 2016, the SAFE intervention has reached 510 districts in Ethiopia, and 
871,646 peoples received TT surgery for trichiasis from 2003 to end of 2014. In addition more 
than 186 million people have been treated with annual Zithromax since the program start the 
programme in 2003[5]. More than 20 million school aged children have been treated for 
schistosomiasis and STH yearly since 2007[5]. MDA for onchocerciasis in west Ethiopia has 
reduced the prevalence of microfilaridermia by 46% between 2006 and 2012[26] . Similarly, 
annual MDA for LF has been implemented since 2009, and by 2015 nearly two million individuals 
were treated[5].  
 
Despite the remarkable progress in fighting NTDs, several bottlenecks must be addressed to 
eliminate NTDs in Ethiopia during the SDG era. First, the co-existence of HIV with common 
NTDs such as leishmaniasis pose a diagnostic and treatment challenge. Diro et al have reported 
that the use of antimonials for the treatment of leishmaniasis in HIV patients could result in 
treatment failure [27]. The slow reductions in leishmaniasis mortality and DALY rates reported 
here could be the result of treatment failures that demand new drugs be made available to reduce 
mortality.  Second, individuals with NTDs such as LF, trachoma and onchocerciasis are prone to 
social stigma and discrimination, and requires strong community engagement and mobilization 
activities to address that stigma and improve intervention coverage[28]. Third, some NTDs such 
as rabies are zoonotic diseases that require a one health approach and collaboration with veterinary 
medicine. The one health approach emphasizes the linkage and collaboration between human and 
animal health and the environment [2,29]. Lastly, Ethiopia’s future economy will be based on 
mega projects such as hydroelectric dams and irrigation systems that might favor the breeding of 
mosquitoes and transmission of vector borne diseases such as LF that calls for tailored 
interventions in such high-risk areas [30-32]. 
 
GBD is the first study to provide comprehensive estimates of mortality and DALYs for NTDs 
during the MDG era. However, the study has some limitations. First, quantity of data for estimation 
of DALYs and mortality rates are sparse in Ethiopia that makes the uncertainty intervals very wide 
(Table 2 and figure 2). Second, GBD 2015did not produce sub-national estimates for Ethiopia and 
we are, therefore, unable to describe heterogeneity in the burden of NTDs within Ethiopia.  
 
Ethiopia has made remarkable progress in reducing DALY rates for trachoma, onchocerciasis and 
some STH such as ascariasis. Slow progress has been observed for LF and leishmaniasis. Ethiopia 
should continue to strengthen integrated intervention coverage for NTDs through proper 
coordination with other health programs and sectors, and community participation to eliminate 
NTDs by 2020. The health management information system for NTDs should be strengthened by 
districts and regions to track progresses during the SDG period.  
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Table 1: Number of deaths and mortality rate of malaria and common neglected tropical diseases in Ethiopia, both sex between 1990 
and 2015 
 
Diseases 
1990 2015 Median % change 
mortality rate, 1990-
2015 
Number of deaths 
(95% UI) 
Deaths/100,000 
(95%UI) 
Number of 
deaths(95%UI) 
Deaths/100,000 
95%UI) 
All NTDs 6293(3699, 10080) 15.5(10.6,23.2) 3593(2051, 6178) 3.9(2.2,7.0) -70.0 
Schistosomiasis 993.4(599.2, 1470.7) 6.1(3.5,9.4) 249.4(118.1,453.4) 0.53(0.23,1.0) -91.3 
Leishmaniasis 373.9(139.0, 800.8) 0.74(0.3,1.49) 615.0(248.5,1240.3) 0.58(0.23,1.22) -21.6 
Intestinal nematode 
infections 300.2(89.7,481.4) 0.34(0.12,0.54) 122.6(69.1,184.9) 0.09(0.05,0.13) -73.5 
Rabies 1786.9(854.9,3159.1) 4.1(2.2,6.6) 1242.5(632.6,2659.3) 1.5(0.72,3.33) -63.1 
 
Table 2:  Number of DALY and DALY rates for common neglected tropical Diseases in Ethiopia, 
both sexes between 1990 and 2015 
Diseases 
1990 2015 Median % 
change 
DALY rate, 
1990-2015 
Number of 
DALYs(95%UI) DALYs/100,000 
Number of 
DALYs(95%UI) DALYs/100,000 
All NTDs 
814410 
(548520, 1223541) 
1762 
(1249.9, 2650.9) 
579574 
(309380,1309453) 
1225.6 
(653.2,2741.3) -30.4 
Schistosomiasis 
208298.3 
(122544.6) 547.8(338.2, 924.1) 
367556.8 
(187441.7,695405.3) 
386.8 
(192.1,747.2) -29.4 
Leishmaniasis 
26442.9 
(9993.4,56347.4) 44.6(18.9,90.9) 
43850.3 
(18879.3,84765.2) 
36.8 
(16.3,70.8) -17.5 
Lymphatic Filariasis 
54734.6 
(29059.1(93370.2) 159.4(83.2,271.8) 
105045.2 
(54565.3,176643.9) 
139.4 
(70.5,238.4) -12.5 
Onchocerciasis 
44137.2 
(21847.5,77146.4) 129.7(66.4,228.9) 
31214.4 
(13580.3,57597.1) 
43.9 
(20.0,81.7) -66.2 
Intestinal nematode 
infections 
57277.9 
(36196.2,81770.6) 91.9(61.3,131.9) 
82707.6 
(53644.3,123177.1) 
73.0 
(45.7,111.1) -20.6 
Ascariasis 
29763.8 
(11887.3,45399.6) 35.9(16.9,53.5) 
19752.9 
(,12837.7,28278.9) 
15.5 
(10.2,22.7) -56.8 
Trichuriasis 
4566.0 
(2527.6,7843.0) 8.8(4.7,15.2) 
9299.7( 
4998.7,15531.7) 8.6(4.6,14.4) -2.3 
Hookwork 
22948.1 
(14309.7,35072.0) 47.1(29.0,73.5) 
53654.9 
(33334.6,81706.4) 
48.9 
(29.5,75.8) 3.8 
Trachoma 
18211.7 
(12257.1,25644.5) 92.7(63.2,128.4) 
17293.6 
(11505.2,25198.7) 
41.2 
(27.4,59.2) -55.6 
Rabies 
112196.8 
(47222.9,214928.3) 
200.4 
(99.8,339.6) 
74287.4 
(37885.7,158420.8) 
69.3 
(34.4,148.4) -65.4 
  
Figure 1. Trends of age-standardised mortality rates for all NTDs, Schistosomiasis, Leishmaniasis and rabies, 1990-2015 
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Figure 2. Mortality rate due to schistosomiasis, leishmaniasis and intestinal nematode by age groups and sex in 2015  
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Figure 3. Trends of age-standardised DALY rates for common NTD, both sexes, 1990-2015 
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Figure 4. DALY rates for common NTDs by age group and sex in 2015 
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